Rexahn Pharmaceuticals is a biopharmaceutical company that is primarily focused on developing treatments for cancer and disorders of the central nervous system. The company is in the early stages of development, and is seeking to discover new drugs to treat these diseases. With a strong focus on research and development, Rexahn Pharmaceuticals is poised to become a leading player in the biopharmaceutical industry.